2023-05-09 19:00 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.91 | News Release200 | Aeterna loses $4.3-million (U.S.) in Q1 |
2023-05-09 17:08 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.91 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-05-09 17:08 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.91 | SEDAR MD & A815 | SEDAR MD & A |
2023-04-05 09:11 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.39 | News Release200 | Aeterna to stop sales of Macrilen in U.S. May 23 |
2023-03-23 12:40 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.65 | News Release200 | Aeterna Zentaris loses $22.7-million (U.S.) in 2022 |
2023-03-23 08:14 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.65 | SEDAR Annual Report803 | SEDAR Annual Report |
2023-03-23 08:13 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.65 | SEDAR MD & A815 | SEDAR MD & A |
2023-03-23 08:08 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.65 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2023-03-16 11:26 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.65 | News Release200 | Aeterna partner licenses Ghryvelin to Pharmanovia |
2023-01-17 15:42 | CC:AEZS | Aeterna Zentaris Inc (4) | 5.24 | News Release200 | Aeterna hopes for Detect trial OK in H1 |
2022-12-02 08:29 | CC:AEZS | Aeterna Zentaris Inc (4) | 5.18 | In the News525 | Globe says Buhler, others good for bargain hunters |
2022-11-03 11:39 | CC:AEZS | Aeterna Zentaris Inc (4) | 5.58 | News Release200 | Aeterna loses $3.4-million (U.S.) in Q3 2022 |
2022-11-03 08:39 | CC:AEZS | Aeterna Zentaris Inc (4) | 5.58 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2022-11-03 08:39 | CC:AEZS | Aeterna Zentaris Inc (4) | 5.58 | SEDAR MD & A815 | SEDAR MD & A |
2022-08-29 09:31 | CC:AEZS | Aeterna Zentaris Inc (4) | 6.63 | News Release200 | Aeterna to regain full rights to macimorelin from Novo |
2022-08-03 19:14 | CC:AEZS | Aeterna Zentaris Inc (4) | 6.335 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2022-08-03 19:14 | CC:AEZS | Aeterna Zentaris Inc (4) | 6.335 | SEDAR MD & A815 | SEDAR MD & A |
2022-08-03 18:59 | CC:AEZS | Aeterna Zentaris Inc (4) | 6.335 | News Release200 | Aeterna loses $4.2-million (U.S.) in Q2 |
2022-07-19 20:10 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.265 | Rollback291 | Aeterna Zentaris 1:25 share rollback |
2022-07-18 17:14 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.28 | News Release200 | Aeterna's 1:25 share rollback to take effect July 21 |
2022-07-15 16:29 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.295 | News Release200 | Aeterna receives shareholder OK for 1:25 share rollback |
2022-07-06 16:49 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.26 | News Release200 | Aeterna further adjourns meeting, hopes for rollback OK |
2022-06-21 16:58 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.23 | News Release200 | Aeterna Zentaris adjourns meeting to seek rollback OK |
2022-06-13 12:14 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.25 | News Release200 | Aeterna reaches proof of concept for NMOSD program |